drugset / Trial / NCT05232279

Effect of Testofen on Erectile Function in an Adult Male Population

NCT05232279 ↗

Phase 3 Recruiting 120 enrolled RDC Clinical Pty Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.

Timeline

Start
2022-04-19
Primary completion
2026-06
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Testofen Unknown 300 mg Oral
Subject Testofen Unknown 600 mg Oral

Indications